TITLE

Cardiovascular Effects of Polycyclic Antidepressants

AUTHOR(S)
Mahapatra, Rajat K.; Paul, Subir K.; Mahapatra, Dipta; Winter, Scott
PUB. DATE
October 1986
SOURCE
Angiology;Oct1986, Vol. 37 Issue 10, p709
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Every day, thousands of people in the United States receive polycyclic antide-pressants (PCAs) prescribed by their primary care physicians. We have examined the cardiovascular manifestations of polycydlic antidepressants in 14 patients with primary depression receiving various antidepressant drugs for a period of six months or more. None had suffered from any systemic illness. All 14 received a commonly prescribed PCA, such as doxepin, amitriptyline, imipramine, desipramine or amoxapine, in therapeutic doses. None developed any significant adverse reaction. Left ventricular function, as determined by M-mode echocardiogram, was within normal limit in all patients. A twenty-four-hour ambulatory electrocardiogram revealed rare supraventricular ectopic beats in S patients and ventricular ectopic activity (Lown grade 1) in 4 patients. In 1 patient, who received additional lithium carbonate for treatment of depression, both supraventricular and ventricular ectopic activity developed on rare occasions. In 4 of the 8 patients the plasma concentration of PCA was optimal or near optimal, and in 4 of the S patients it was subtherapeutic (even though these 4 patients had shown clinical improvement with continued polycycic therapy). It appears from the present data that antidepressant therapy with PCA.S prescribed in therapeutic doses was well tolerated, without any significant adverse cardiovascular reaction, in otherwise healthy young patients with primary depression.
ACCESSION #
16479178

 

Related Articles

  • Basic Chemistry.  // Canada & the World Backgrounder;Mar2012, Vol. 77 Issue 3, p3 

    The article focuses on the different kinds of drugs and their effects on the human body. It offers information on endogenous drugs which occur naturally in human bodies such as endorphins, and exogenous drugs which are created outside the human body such as antidepressants which restores the...

  • What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.  // BMC Clinical Pharmacology;2011, Vol. 11 Issue 1, p16 

    The article presents a study that aimed to analyze consumer reports on psychiatric adverse drug reactions with antidepressant medication. In total 665 reports were made during the period January 2002 to April 2009. 442 reports concerned regarding antidepressant medications and the individual...

  • PEARLS.  // New Zealand Doctor;10/10/2007, p15 

    The article provides information on antidepressants which are effective in aiding long-term smoking cessation. When compared to placebo, both bupropion and nortriptyline increase the odds of smoking cessation. Both drugs have their respective side effects. No evidence of benefit for smoking...

  • Cannabinoids: reward, dependence, and underlying neurochemical mechanisms–a review of recent preclinical data. Tanda, Gianluigi; Goldberg, Steven R. // Psychopharmacology;2003, Vol. 169 Issue 2, p115 

    Background and rationale. Starting with the discovery of an endogenous brain cannabinoid system with specific receptors and endogenous ligands, research in the cannabinoid field has accelerated dramatically over the last 15 years. Cannabis is the most used illicit psychotropic substance in the...

  • Evidence debased medicine. Groves, Trish // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;10/16/2010, Vol. 341 Issue 7777, preceding p787 

    The article discusses various reports published within the issue, including one on an analysis of evidence uncovered about the benefits and harms associated with several treatments, a health technology assessment of the antidepressant reboxetine, and one on the failure to enforce reporting of...

  • A New Assessment Of Depression Drugs.  // HealthFacts;Jul99, Vol. 24 Issue 7, p4 

    Reports on the assesment of antidepressant drugs by scientists and researchers. Who assembled the teams; How did they come up with the results; List of the findings.

  • So long to Serzone. Cohen, Sharon; Kritz, Fran // Shape;Aug2004, Vol. 23 Issue 12, p96 

    Presents information on the anti-depressant Serzone.

  • Neuroprotective effects of antidepressant and mood stabilizing drugs. Young, L. Trevor // Journal of Psychiatry & Neuroscience;Jan2002, Vol. 27 Issue 1, p8 

    Editorial. Examines the neuroprotective effects of antidepressants and mood stabilizing drugs. Increase in the expression of several neuroprotective factors due to long-term treatment with lithium and anticonvulsants; Protection provided by mood stabilizing drugs to primary neuronal cultured...

  • Monitoring plasma concentrations of psychotropic drugs.  // British Medical Journal;9/1/1979, Vol. 2 Issue 6189, p513 

    Focuses on the need for monitoring the plasma concentrations of psychotropic drugs in London, England. Preparation of various psychotropic drugs at the Ciba Foundation symposium; Determination of the drug treatment for epilepsy; Effect of plasma drug concentration measurement on the efficacy of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics